TickerFacts.

Adaptimmune Therapeutics PLC (ADAPY): EPS (Basic)

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$0.05
Year ended 2024-12-31
2019-12-31: -$0.222020-12-31: -$0.152021-12-31: -$0.172022-12-31: -$0.172023-12-31: -$0.092024-12-31: -$0.05-$0.05
2019-12-31 EPS (Basic) (USD per share) 2024-12-31
Period endedEPS (Basic)Change YoYSource filing
2024-12-31-$0.05n/m2025-03-24, From 2024-01-01
2023-12-31-$0.09n/m2025-03-24, From 2023-01-01
2022-12-31-$0.17n/m2025-03-24, From 2022-01-01
2021-12-31-$0.17n/m2024-03-06, From 2021-01-01
2020-12-31-$0.15n/m2023-03-06, From 2020-01-01
2019-12-31-$0.22n/a2022-03-14, From 2019-01-01